The direct answer: Profhilo is an injectable hyaluronic acid treatment designed mainly to improve skin quality rather than build a new facial shape. The classic 2 mL product contains 64 mg of hyaluronic acid: 32 mg of high-molecular-weight HA and 32 mg of low-molecular-weight HA. A patented thermal process allows those two sizes of HA to form cooperative complexes without the BDDE chemical cross-linking commonly used to make structural HA fillers hold their shape.
That is why the most accurate description is not a traditional volumising or contouring filler. Profhilo can bind water, spread through a broader tissue area and may gradually improve hydration, texture and elasticity. It is not designed to project a chin, shape lips, rebuild a cheek or erase one deep fold. Temporary plumping or swelling can occur, but that is different from planned structural volume.
The clearest initial treatment framework in the product instructions is two sessions 30 days apart. A useful result review is usually made around four to eight weeks after the second session, when early swelling has gone and gradual skin-quality changes have had time to develop. Results are subtle and variable, and the published human evidence is promising but much smaller and more industry-linked than many clinic pages suggest.
What this guide covers: the classic Profhilo 3.2% product containing 64 mg in 2 mL. It explains ingredients, mechanism, realistic benefits, timing, treatment planning, aftercare and safety without giving injection point maps, depths, volumes or DIY instructions.
Which Profhilo product does this guide mean?
“Profhilo” is now a product family, so the name on its own is not enough. This guide concerns the classic white-and-copper 2 mL Profhilo product currently listed by MJS. It should not be confused with Profhilo Structura or Profhilo Body; they are separate products with different presentations and treatment objectives.
| Product | What identifies it | Main decision it is designed to address | What not to assume |
|---|---|---|---|
| Classic Profhilo 2 mL | 64 mg total HA: 32 mg H-HA + 32 mg L-HA | Diffuse skin-quality improvement, hydration, elasticity and mild skin-laxity concerns | It is not intended to create the localized projection of a cheek, chin or lip filler |
| Profhilo Structura | 90 mg total HA in 2 mL in the published product literature | A separate product studied and positioned for adipose-tissue restoration and deeper facial support | Its evidence, formulation and treatment plan cannot be copied onto classic Profhilo |
| Profhilo Body | A separate 3 mL body presentation in the published literature | Skin laxity and tissue quality in selected body areas | “Body” is not merely a larger box of classic facial Profhilo |
The distinction matters because Google searches for “what is Profhilo” frequently surface pages about Structura, classic Profhilo and body treatment together. A published Profhilo Structura paper describes 45 mg each of high- and low-molecular-weight HA in 2 mL and an adipose-restoration objective. That is not the formulation being explained in this article.
Is Profhilo a filler? The precise answer
Profhilo is an HA injectable with some filling and water-binding effects, but it is not a traditional shape-holding dermal filler. Saying simply “it is not a filler” is convenient marketing shorthand; it hides the more useful difference—how the material behaves and what result the treatment is supposed to create.
The product’s own instructions use terms including corrective or filling action, while its commercial category is “bioremodelling.” Those statements are not necessarily contradictory. A fluid HA product can occupy space and attract water without being designed to remain as a sculpted bolus that projects a facial feature.
| Question | Classic Profhilo | Traditional structural HA filler |
|---|---|---|
| Primary goal | Improve skin hydration, texture, elasticity and the appearance of mild laxity across an area | Replace or add localized volume, support a contour, project a feature or soften a specific fold |
| HA structure | Thermally stabilised high- and low-molecular-weight HA cooperative complexes; no BDDE chemical cross-linking | Many structural HA fillers use chemical cross-linking, commonly with BDDE, to increase shape retention and persistence |
| Material behaviour | Low viscosity and high spreadability are central to the product concept | Elasticity, cohesivity and resistance to deformation are selected to suit a defined structural job |
| Expected visual change | Diffuse, gradual and usually subtle skin-quality change | More localized and often immediately visible contour or volume change |
| Best question to ask | “Is my concern mainly skin quality?” | “Is my concern a specific volume or structural deficit?” |
Can Profhilo still make the face look fuller or puffy?
Yes, it can create temporary fullness because HA binds water and any injection can cause local swelling. Small raised deposits can also be visible immediately after treatment. Neither effect proves that a lasting volumising result has been created.
This distinction helps explain mixed social-media reactions. Someone who wants subtle hydration may welcome a fresher, slightly plumper look. Someone already prone to facial or under-eye fluid retention may dislike even temporary puffiness. Candidate selection therefore matters as much as the product name.
What is Profhilo made of?
Classic Profhilo 2 mL is a buffered solution of two molecular sizes of sodium hyaluronate, plus sodium chloride, sodium phosphate and water for injection. The current formula lists 32 mg of high-molecular-weight HA and 32 mg of low-molecular-weight HA. It does not list lidocaine, and its HA is not chemically cross-linked with BDDE.
The Profhilo instructions for use identify the two HA fractions and explain that both are produced by biofermentation without chemical modification.
High-molecular-weight HA: the water-binding, structure-supporting fraction
The 32 mg H-HA fraction has a stated molecular-weight range of approximately 1,100–1,400 kDa. Large HA chains are highly hydrophilic and contribute to the extracellular matrix environment. In this formula, they also contribute to the viscoelastic and slower-degrading part of the cooperative complex.
It is too simplistic to say that H-HA “lifts the face” on its own. Its useful role is better understood as helping the formula retain water and maintain a more persistent matrix-like presence while remaining part of a fluid product.
Low-molecular-weight HA: the smaller-chain partner
The 32 mg L-HA fraction has a stated molecular-weight range of approximately 80–100 kDa. Combining smaller chains with H-HA helps the finished product reach a high HA concentration without behaving like an extremely thick gel. The smaller fraction also participates in HA receptor signalling in laboratory models, but molecular size alone does not predict a patient’s visible result.
Claims such as “L-HA stimulates collagen while H-HA hydrates” are therefore too neat. The commercial product is a combined complex, and the clinical question is what the complete formula does in people—not what one isolated chain might do in a dish.
NAHYCO: what “thermal stabilisation” actually means
NAHYCO is a patented heating-and-cooling process that encourages weak interactions between the high- and low-molecular-weight HA chains. According to IBSA’s technology explanation, the process forms stable cooperative hybrid complexes without adding chemical cross-linking reagents.
The practical consequence is a high total concentration—64 mg in 2 mL—with comparatively low viscosity and broad spreadability. Unlike a covalently cross-linked structural filler, Profhilo is not engineered primarily to resist deformation and hold a sculpted shape.
What does “BDDE-free” mean—and what does it not mean?
BDDE-free means the formula is not stabilised with the 1,4-butanediol diglycidyl ether cross-linker commonly used in many HA fillers. It does not mean chemical-free, reaction-free or risk-free. Profhilo is still a sterile implantable medical product, and the risks associated with skin penetration, infection, inflammatory reaction and vascular injury still require qualified clinical care.
How does Profhilo work?
The most defensible explanation has three layers: HA binds water, the fluid hybrid complex distributes through tissue, and a gradual tissue-response hypothesis may contribute to later changes. The first two are supported by the product’s composition and rheology. The third is biologically plausible, but its clinical proof is less complete than the phrase “stimulates four types of collagen and elastin” suggests.
1. Immediate physical effect: HA attracts and retains water
Hyaluronic acid is a normal component of the extracellular matrix and can bind large amounts of water. Once placed in tissue, Profhilo therefore has an immediate hydration and space-occupying effect. Early glow or plumping may be partly related to water and post-procedure swelling, so it should not be mistaken for the final result.
2. Distribution effect: low viscosity supports a diffuse skin-quality goal
The hybrid complex has fluid-dominant rheology rather than the strong shape-retaining behaviour selected for many contour fillers. It can therefore influence a wider tissue area instead of being used to build one sharply defined feature. This is the physical reason the product is matched to skin-quality and laxity goals rather than lip shaping or chin projection.
3. Biological response: plausible, but not a guaranteed collagen programme
Laboratory studies and manufacturer materials describe effects on fibroblasts, keratinocytes, extracellular-matrix proteins and elastin. However, the much-cited 2016 laboratory paper that reported collagen and elastin expression now carries a 2024 Expression of Concern from the journal. It should not be used as settled proof that a treatment will create a specific amount of new collagen or visible lifting in a person.
Human studies do report changes in hydration, transepidermal water loss, texture, elasticity or laxity measures, but most do not take biopsies that directly demonstrate the marketing version of “bioremodelling.” The honest conclusion is that Profhilo has a credible physical hydration/distribution mechanism and an evolving biological hypothesis; visible outcomes still need to be judged clinically.
What does the clinical evidence actually show?
The evidence supports possible improvement in hydration and several skin-quality measures, but it does not support a guaranteed lift, a universal six-month duration or superiority over every skin booster. Most Profhilo studies are small, single-centre and connected to the product company.
| Evidence level | What was found | What it can reasonably support |
|---|---|---|
| 2026 systematic review | Nine Profhilo/Profhilo Body studies with 278 participants reported improvement or improvement trends across hydration, elasticity, density, laxity and wrinkle-related measures | The product has more than anecdotal support for skin-quality change |
| 2025 Asian open-label study | Thirty Chinese women were enrolled; treatment at weeks 0 and 4 was followed to week 12. Superficial hydration and TEWL improved significantly at week 12, while several other pairwise outcome comparisons were not significant | Hydration and barrier-related changes are plausible; dramatic facial change is not proven |
| 2022 neck study | Twenty-five people received two sessions 30 days apart and were assessed for roughness, laxity, hydration, density and elasticity-related measures | Neck skin quality may improve, but the study is small and uncontrolled |
| Laboratory evidence | Cell and reconstructed-skin models have reported extracellular-matrix signals | Useful for a hypothesis, not a promise of visible collagen production or lifting |
The 2026 systematic review is useful because it collects the available human studies, but its limitations are central: every included study was single-centre, six enrolled fewer than 30 people, only one included men, methods varied, the review was funded by IBSA and three authors were IBSA employees. That does not make the results false; it lowers how confidently they can be generalized.
The 2025 Asian facial study is similarly informative but modest. It is open-label and single-centre, only 26 participants reached the final follow-up for most outcomes, and the hydration analysis used still fewer measurements. Customers should hear both the positive result and the size of the evidence behind it.
What are the realistic benefits of Profhilo?
The most realistic benefits are better hydration, smoother-looking texture, a fresher surface, improved elasticity-related feel and a subtle improvement in mild crepiness or laxity. The change is usually better described as “the skin looks healthier” than “the face has been reshaped.”
Profhilo may be a reasonable discussion when the main concern is:
- dehydrated or crepey-looking skin;
- early loss of elasticity or firmness;
- fine surface lines that become more visible with dryness;
- mild laxity of the face or neck;
- a desire for diffuse skin-quality improvement without intentional feature projection.
It is a poor match when the main goal is:
- lip shape or lip volume;
- chin, jaw or cheek projection;
- replacement of a clear structural volume deficit;
- predictable correction of one deep fold;
- major lifting of advanced laxity;
- treatment of eye bags, significant fluid retention or every type of dark circle;
- a dramatic one-session before-and-after change.
Why do some people see “no result”?
A person can complete two sessions and still judge the result as small or not worthwhile. Common reasons include choosing a skin-quality product for a structural problem, expecting filler-like change, having a subtle baseline concern, inconsistent photographs, judging too early, or simply responding less than another patient.
The lack of a dramatic change is not always treatment failure; subtlety is part of the product’s intended positioning. But subtlety should not be used to dismiss every disappointed customer. Define one measurable goal before treatment and compare it under the same lighting, angle, expression and skincare conditions after the full initial course.
When do Profhilo results appear?
Do not judge the final result from the first few days. Early bumps, swelling and water-related plumping can make the skin look temporarily better or worse. A more useful assessment begins after the second session and continues through approximately weeks 8–12 from the start of the course.
| Time | What may be visible | How to interpret it |
|---|---|---|
| Same day to first few days | Raised points, redness, tenderness, warmth, bruising or swelling; sometimes an early glow or plump look | This is recovery plus hydration, not the final result. The overall trend should be toward settling, not worsening |
| Around week 4 | Early texture or hydration change may be easier to see; the second session is commonly scheduled at this point | One month is an interim checkpoint, not proof of peak effect |
| Weeks 8–12 | Hydration, surface smoothness and elasticity-related changes are more meaningfully compared after the two-session course | Use consistent photographs and decide whether the original goal improved |
| Months 3–4 | Some small studies continue to record skin-quality or laxity-related changes | Evidence is still limited; duration varies by area, baseline and individual response |
| Later maintenance window | Benefits may gradually fade rather than stop on one date | Do not book maintenance from a universal internet calendar; base it on prior response and current local guidance |
The 2025 Asian study measured its clearest hydration and TEWL changes at week 12. The 2022 neck study followed participants to four months from the first treatment. Neither study establishes one exact “peak” or duration for everybody.
What Profhilo treatment course gives the best realistic result?
The best-supported starting plan is two sessions separated by 30 days, followed by a planned review—not an open-ended package of injections. That schedule appears in the product IFU and is also the framework used in several clinical studies.
A practical evidence-aware course
- Before session one: identify one primary concern, rule out a structural problem better suited to another treatment, record standardized photographs and review medical history, previous injectables and upcoming procedures.
- Session one: begin the initial course under the current local instructions and a qualified practitioner’s plan.
- Around day 30: reassess recovery and any early change, then complete the second session if the treatment remains appropriate.
- Four to eight weeks after session two: compare the original goal and photographs. This places the main review around weeks 8–12 from baseline.
- Maintenance decision: repeat only if the first course produced a worthwhile change and symptoms have fully settled. The interval should follow the current jurisdiction-specific instructions and clinical reassessment.
Why this article does not give one universal maintenance interval
Official Profhilo materials are clearer about the initial course than maintenance. An older IFU says maintenance may be considered every two months according to the degree of ageing, while an official brochure describes treatment frequency as twice per year. Clinic pages often state six to nine months. Those are not the same instruction.
The defensible approach is to preserve the well-supported two-session start, review the actual response, and use the current local IFU rather than copying the most frequent or most aggressive maintenance claim online. More sessions do not guarantee more benefit, and product amount cannot be chosen from a blog post.
What improves the chance of a useful outcome?
- Choose a skin-quality goal, not a filler-shaped goal.
- Treat active inflammation, infection or unstable skin disease before an elective injectable procedure.
- Keep baseline and review photos consistent.
- Maintain sensible daily sun protection; UV exposure can obscure improvements in tone and texture.
- Avoid stacking lasers, medium/deep peels or other inflammatory procedures into the same period without a clinician-led sequence.
- Judge value after the planned review instead of buying maintenance in advance.
Profhilo aftercare: what should you do after treatment?
Protect the treated skin, avoid unnecessary pressure and irritation, and watch whether common reactions are improving. The instructions from the treating professional and the current product leaflet take priority, because area, technique, medical history and local rules can change the plan.
| Time after treatment | Practical aftercare | Why it matters |
|---|---|---|
| Remainder of the day | Keep the area clean; do not pick, press or repeatedly check raised points. Use little or no makeup if possible. Do not massage unless the treating clinician specifically tells you to | Reduces contamination and mechanical irritation while the puncture sites are fresh |
| First 24 hours | Avoid strenuous exercise. Avoid rubbing the face or sleeping face-down if it places pressure on treated areas | Heat, friction and pressure can aggravate redness, swelling or bruising |
| Following 3–5 days | Avoid unnecessary UV exposure and use high-protection broad-spectrum sunscreen over the treated area, as advised in the Profhilo IFU | This is a product-specific aftercare instruction and also protects recovering skin |
| Until the skin is calm | Delay facials, devices or aggressive active products that irritate still-red or tender skin | Symptoms, rather than a sales calendar, should guide return to optional procedures |
| For other procedures | Do not schedule Profhilo concurrently with laser resurfacing or medium/deep chemical peeling; ask the treating clinicians to coordinate timing | The IFU specifically warns against concurrent use with these treatments |
The general facial HA injection consensus recommends avoiding strenuous activity for 24 hours, not rubbing or sleeping face-down for a week and not self-massaging for two weeks unless the injector directs it. The same paper labels some of this practical advice as consensus rather than high-level evidence, so it should guide common-sense care, not replace the product-specific instructions.
Should you massage Profhilo bumps?
Do not independently massage a bump because an online post says it will spread the product. The clinician may perform or recommend specific aftercare, but patient massage can add pressure, contamination and confusion when a persistent lump actually needs assessment. Ask the clinic that performed the procedure.
What side effects are common, and which signs are urgent?
Redness, tenderness, warmth, bruising, swelling and small raised points are expected short-term possibilities. They should generally become less noticeable rather than more painful, discoloured or swollen. A persistent lump deserves review even if it is not an emergency.
Common short-term reactions can include:
- visible injection bumps or temporary unevenness;
- local redness, heat or tenderness;
- mild swelling or fluid-related puffiness;
- bruising, itching or sensitivity;
- discomfort during or shortly after treatment.
Contact the treating clinic promptly if a lump is not settling, or if redness, warmth, pain, itching or swelling is increasing rather than improving. Also contact the clinic for drainage, fever, a new rash, delayed swelling or any reaction that feels different from the written recovery plan.
Seek urgent medical assessment for:
- any change in vision, eye pain or sudden visual disturbance;
- severe or escalating pain;
- pale, white, dusky or net-like mottled skin;
- an unusual or rapidly expanding bruise-like pattern;
- pustules or blisters after treatment;
- rapidly increasing swelling, breathing difficulty or other signs of a severe allergic reaction;
- sudden weakness, speech difficulty or another neurological symptom.
These warning signs do not mean Profhilo commonly causes a vascular event. They mean that rare injection complications are time-sensitive and should never be dismissed as normal “downtime.” The HA vascular-occlusion guideline specifically identifies pallor, dusky colour and reticulated change as signs requiring immediate assessment.
Why do published side-effect numbers look contradictory?
Actively collected study reactions and passive safety complaints measure different things. The 2026 review calculated an average adverse-event rate of 46% across six small studies, largely reflecting expected local events such as bruising, edema, pinching sensation, bumps and hematomas. A 2025 global post-marketing analysis reported 371 events against an estimated 1,091,956 exposed classic Profhilo patients—0.034%.
The second number is not proof that only 0.034% of patients experience redness or swelling. Post-marketing systems depend on complaints being reported, while a study actively asks and examines participants. Passive surveillance is useful for spotting patterns but can substantially undercount routine or mild reactions.
Who is a good candidate for Profhilo—and who may not be?
The most logical candidate has a mild-to-moderate skin-quality concern, accepts a subtle gradual result and does not need localized structural volume. Age alone does not decide suitability. Baseline anatomy, tendency to swell, active skin conditions, medical history, previous injectables and expectations all matter.
Treatment is commonly postponed or may be unsuitable when there is active infection, inflamed or damaged skin, an uncontrolled skin condition, pregnancy or breastfeeding, relevant hypersensitivity, significant immune or bleeding concerns, or a previous unexplained reaction to an injectable product. Medicines and supplements that affect bleeding should be discussed with the prescriber and treating clinician; do not stop prescribed medication because of an online article.
Is Profhilo good for under eyes?
Profhilo is not automatically an under-eye treatment, and “dark circles” are not one diagnosis. Thin crepey skin, pigment, a hollow, visible vessels, fluid retention and fat-pad prominence require different decisions. A person prone to eyelid or malar edema may be especially dissatisfied by temporary water-related puffiness.
Do not assume that classic Profhilo can replace tear-trough filler or that placing it close to the eye is appropriate because it is “not a filler.” The exact area, product version and treatment plan require an experienced medical assessment.
Is Profhilo FDA-approved or available everywhere?
Regulatory status varies by country. Classic Profhilo 3.2% is listed in Australia’s ARTG as a Class III medical device, with registration dating from April 2022. It is not currently FDA-approved in the United States as of this review. A July 2026 Evolus–IBSA announcement states that US development and regulatory-approval activities are still required.
Availability from an online distributor does not establish approval for every procedure or jurisdiction. Professional buyers and practitioners should verify the exact local label, import rules, advertising rules and scope-of-practice requirements.
Profhilo 2 mL specifications
The specification confirms which product is being discussed; it does not determine a patient’s treatment amount or expected result.
| Item | Classic Profhilo 2 mL |
|---|---|
| Product | Profhilo 3.2% |
| Total hyaluronic acid | 64 mg in 2 mL |
| H-HA | 32 mg; approximately 1,100–1,400 kDa |
| L-HA | 32 mg; approximately 80–100 kDa |
| Technology | NAHYCO thermally stabilised hybrid cooperative complexes |
| Chemical cross-linker | No BDDE or other chemical cross-linking agent listed |
| Other listed components | Sodium chloride, sodium phosphate and water for injection |
| Lidocaine | Not listed in the classic formula |
| Presentation | One sterile, single-use pre-filled 2 mL syringe; package includes two needles |
| Initial course in IFU | Two sessions at a 30-day interval; individual reassessment required |
| Intended user | Qualified healthcare professional under local rules |
Professional buyers can check the current packaging and commercial presentation on the MJS Profhilo 2ml product page. MJS supplies the product as a distributor; it is not the manufacturer and does not determine clinical suitability.
Frequently asked questions
Is Profhilo a dermal filler?
Not in the traditional volumising or contouring sense. It is an injectable HA product with high spreadability and a skin-quality objective. It can bind water and temporarily occupy space, but it is not designed to sculpt a localized facial feature.
Is Profhilo a skin booster?
“Skin booster” is understandable but broad. Profhilo is often grouped with skin boosters because the goal is hydration and skin quality rather than structural projection. “Hybrid-HA bioremodelling product” is more specific to its formula and positioning.
What is in Profhilo?
Classic Profhilo 2 mL contains 32 mg of high-molecular-weight and 32 mg of low-molecular-weight sodium hyaluronate, plus sodium chloride, sodium phosphate and water. The HA is thermally stabilised without BDDE chemical cross-linking.
Does Profhilo add volume?
It may cause temporary water-related plumping and swelling, but it is not designed to deliver the controlled structural projection of a volumising filler. Someone with a true cheek, chin, lip or deep-fold volume deficit needs a different assessment.
How many Profhilo sessions are normally planned?
The classic initial course in the IFU is two sessions 30 days apart. The useful question after that is whether the person achieved a meaningful, documented improvement—not how many sessions can be sold.
How long does Profhilo take to work?
Early hydration or glow may be noticed within days, but swelling can confuse that impression. A more useful review is around four to eight weeks after the second session, approximately weeks 8–12 from the start.
How long does Profhilo last?
There is no single well-proven duration for every person and area. Many commercial sources cite around six months, but official maintenance language varies and the available studies are small. Longevity should be assessed from the person’s response rather than promised in advance.
How long do Profhilo bumps last?
Small raised points should trend down over the first few days, although the exact timing varies by tissue, technique and swelling. Do not massage them without instructions. Contact the treating clinic if a bump persists, becomes more painful, changes colour or is accompanied by increasing redness, heat or swelling.
Is Profhilo Structura the same as Profhilo?
No. Structura is a separate 90 mg/2 mL product studied for adipose-tissue restoration and deeper support. Classic Profhilo is 64 mg/2 mL and is primarily discussed for diffuse skin quality and laxity. Their names do not make their treatment plans interchangeable.
Is Profhilo worth it?
It may be worthwhile for someone who wants a subtle skin-quality change and has a measurable hydration, texture or mild-laxity goal. It is less likely to feel worthwhile when the real problem is structural volume, significant lifting, eye bags or a desire for a dramatic one-session transformation.
The buying and treatment decision in one sentence
Choose classic Profhilo when the assessed problem is diffuse skin quality and a subtle two-session course is acceptable; choose a different category when the goal is localized volume, feature projection or major lifting.
Professional buyers can browse the MJS Skin Booster collection or review the current Profhilo 2ml listing. The collection helps compare product categories; the product page confirms the current commercial presentation, while neither replaces the clinical evidence and local instructions described above.
Evidence note: product identity, the two-session initial course and product-specific aftercare come from the Profhilo IFU. Outcome claims are bounded by the available human studies and their limitations. General facial-HA consensus is used only for practical aftercare and warning signs. Social posts shape the questions in this guide but are not evidence of efficacy or risk frequency. Last evidence review: September 6, 2026.
